CTNM

Contineum Therapeutics
CTNM

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$16.67
42% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Morgan Stanley
Morgan Stanley
Jeffrey Hung
67% 1-yr CTNM win rate
8 Jan ‘26 11 days ago
Baird
Baird
Joel Beatty
100% 1-yr CTNM win rate
24 Nov ‘25 1 month ago
RBC Capital
RBC Capital
Brian Abrahams
50% 1-yr CTNM win rate
21 Nov ‘25 1 month ago